TAMPA, Fla. — On Wednesday, the first retail shop broke ground at 400 Central, the part-residential, part-office high rise downtown. But other businesses in that area have mixed reactions. 400 Central ...

The gates of a ranch that has remained in the same family for nearly 80 years are preparing to welcome a new chapter after a nearly 400-acre property north of Montgomery County was sold to a developer ...

Nearly 400 new homes are coming to North Vancouver’s Lynn Valley neighbourhood. District of North Vancouver council approved rezoning Monday, May 25 for Polygon Development 395 Ltd. to build four ...

OnQ, the retail industry’s leading provider of engaging, tech-enabled, secure retail displays and experiences, today announced that its proprietary Converge platform now integrates with IBM ...

Months after purchasing the ground lease of an independent television studio property, ABS Partners Real Estate tipped its hand on what could be coming up next. Randy Modell and Steven Hornstock of ...

After nearly seven years of heated debate, a major development project in Kendall is moving forward. A developer has secured approval to build more than 500 homes on a former golf course in the Calusa ...

A developer is proposing a 400-unit housing and commercial campus in Marlborough. The project would include apartments, townhomes, a commercial building and a parking garage. Greatland Realty Partners ...

The will of a 17th century nobleman could derail the development of a large estate in Thanet. Plans for 1,600 homes in Birchington that had previously been approved by Thanet District Council, have ...

Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded barely eight months ago, in an all-stock deal worth just over $400 million. The acquisition brings a team of fewer than 10 ...

Zcash Open Development Lab (ZODL), a new group formed by the former core team of the Electric Coin Company (ECC), has raised over $25 million in seed funding. The lab emerged after the entire ECC ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...